Markku Pasanen

6.4k total citations
138 papers, 4.8k citations indexed

About

Markku Pasanen is a scholar working on Pharmacology, Molecular Biology and Biochemistry. According to data from OpenAlex, Markku Pasanen has authored 138 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Pharmacology, 52 papers in Molecular Biology and 25 papers in Biochemistry. Recurrent topics in Markku Pasanen's work include Pharmacogenetics and Drug Metabolism (67 papers), Eicosanoids and Hypertension Pharmacology (20 papers) and Drug-Induced Hepatotoxicity and Protection (20 papers). Markku Pasanen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (67 papers), Eicosanoids and Hypertension Pharmacology (20 papers) and Drug-Induced Hepatotoxicity and Protection (20 papers). Markku Pasanen collaborates with scholars based in Finland, United States and United Kingdom. Markku Pasanen's co-authors include Olavi Pelkonen, Hannu Raunio, Risto O. Juvonen, Jukka Hakkola, Päivi Myllynen, Seppo Auriola, Arno J. Arranto, E. A. Sotaniemi, Arja Rautio and Alan R. Boobis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Advanced Drug Delivery Reviews.

In The Last Decade

Markku Pasanen

138 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markku Pasanen Finland 37 1.9k 1.3k 932 739 667 138 4.8k
Jukka Hakkola Finland 44 2.1k 1.1× 1.6k 1.3× 1.1k 1.2× 699 0.9× 526 0.8× 93 5.2k
Petr Pávek Czechia 41 1.2k 0.6× 1.5k 1.1× 1.6k 1.7× 898 1.2× 383 0.6× 159 5.2k
Lauren M. Aleksunes United States 48 1.4k 0.7× 2.8k 2.1× 2.2k 2.4× 1.2k 1.6× 559 0.8× 168 7.0k
Ronald N. Hines United States 45 2.5k 1.3× 1.6k 1.2× 1.2k 1.3× 1.4k 1.9× 1.1k 1.6× 128 6.4k
Janne Hukkanen Finland 26 1.4k 0.7× 1.8k 1.4× 693 0.7× 302 0.4× 585 0.9× 62 5.0k
James W. Paxton New Zealand 35 859 0.4× 1.7k 1.3× 1.4k 1.4× 817 1.1× 173 0.3× 161 4.8k
Hannu Raunio Finland 51 4.3k 2.2× 3.0k 2.3× 2.2k 2.3× 780 1.1× 734 1.1× 168 8.6k
Michael W.H. Coughtrie United Kingdom 42 2.1k 1.1× 2.6k 2.0× 871 0.9× 783 1.1× 695 1.0× 139 6.2k
Bhagwat Prasad United States 40 1.6k 0.8× 1.1k 0.8× 1.8k 2.0× 1.2k 1.6× 120 0.2× 164 4.3k
Angela L. Slitt United States 37 874 0.5× 1.2k 0.9× 1.5k 1.6× 625 0.8× 498 0.7× 78 3.9k

Countries citing papers authored by Markku Pasanen

Since Specialization
Citations

This map shows the geographic impact of Markku Pasanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markku Pasanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markku Pasanen more than expected).

Fields of papers citing papers by Markku Pasanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markku Pasanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markku Pasanen. The network helps show where Markku Pasanen may publish in the future.

Co-authorship network of co-authors of Markku Pasanen

This figure shows the co-authorship network connecting the top 25 collaborators of Markku Pasanen. A scholar is included among the top collaborators of Markku Pasanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markku Pasanen. Markku Pasanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hantunen, Sari, Ari Voutilainen, Anu Ruusunen, et al.. (2024). Maternal caffeine, coffee and cola drink intake and the risk of gestational diabetes – Kuopio Birth Cohort. Primary care diabetes. 18(3). 362–367. 3 indexed citations
2.
Bourcier, Todd, Timothy J. McGovern, Akiyoshi Nishikawa, et al.. (2024). ICH S1 prospective evaluation study: weight of evidence approach to predict outcome and value of 2-year rat carcinogenicity studies. A report from the regulatory authorities subgroup. SHILAP Revista de lepidopterología. 6. 1353783–1353783. 8 indexed citations
3.
Hantunen, Sari, Leea Keski‐Nisula, Juha Pekkanen, et al.. (2022). Longitudinal Analyses of Diet Quality and Maternal Depressive Symptoms During Pregnancy: The Kuopio Birth Cohort Study. Journal of the Academy of Nutrition and Dietetics. 123(1). 77–86.e4. 7 indexed citations
4.
Toffol, Elena, Katri Backman, Raimo Voutilainen, et al.. (2021). The impact of postpartum depressive symptoms on self-reported infant health and analgesic consumption at the age of 12 months: A prospective cohort study. Journal of Psychiatric Research. 136. 388–397. 1 indexed citations
5.
Dekel, Sharon, Tsachi Ein‐Dor, Jussi Lampi, et al.. (2019). The dynamic course of peripartum depression across pregnancy and childbirth. Journal of Psychiatric Research. 113. 72–78. 31 indexed citations
6.
Huuskonen, Pasi, et al.. (2018). Peroxisome proliferator activated receptor gamma (PPAR-γ) ligand pioglitazone regulated gene networks in term human primary trophoblast cells. Reproductive Toxicology. 81. 99–107. 12 indexed citations
7.
Puris, Elena, Markku Pasanen, Mikko Gynther, et al.. (2016). A liquid chromatography-tandem mass spectrometry analysis of nine cytochrome P450 probe drugs and their corresponding metabolites in human serum and urine. Analytical and Bioanalytical Chemistry. 409(1). 251–268. 18 indexed citations
8.
Pesonen, Maija, Merja R. Häkkinen, Kirsi Rilla, et al.. (2014). Chloropicrin-induced toxic responses in human lung epithelial cells. Toxicology Letters. 226(2). 236–244. 18 indexed citations
9.
Pelkonen, Olavi, Markku Pasanen, John C. Lindon, et al.. (2012). Omics and its potential impact on R&D and regulation of complex herbal products. Journal of Ethnopharmacology. 140(3). 587–593. 42 indexed citations
10.
Leppänen, Jukka, Jarkko I. Venäläinen, Markku Pasanen, et al.. (2010). Simple, Direct, and Informative Method for the Assessment of CYP2C19 Enzyme Inactivation Kinetics. Drug Metabolism and Disposition. 39(3). 412–418. 14 indexed citations
11.
Pasanen, Markku. (2004). Species differences in CYP enzymes. 7 indexed citations
12.
Kantola, M., Raija Purkunen, Markku Pasanen, et al.. (2004). Selenium in pregnancy: is selenium an active defective ion against environmental chemical stress?. Environmental Research. 96(1). 51–61. 50 indexed citations
13.
Auriola, Seppo, et al.. (2000). Kinetic characteristics of norcocaine N -hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes. Archives of Toxicology. 74(9). 511–520. 27 indexed citations
14.
Hakkola, Jukka, Olavi Pelkonen, Markku Pasanen, & Hannu Raunio. (1998). Xenobiotic-Metabolizing Cytochrome P450 Enzymes in the Human Feto-Placental Unit: Role in Intrauterine Toxicity. Critical Reviews in Toxicology. 28(1). 35–72. 179 indexed citations
15.
Kojo, Anneli, et al.. (1998). Induction of CYP2A5 by pyrazole and its derivatives in mouse primary hepatocytes. Archives of Toxicology. 72(6). 336–341. 12 indexed citations
16.
Rautio, Arja, et al.. (1996). Coumarin 7-hydroxylation in long-term adherents of a strict uncooked vegan diet. European Journal of Clinical Pharmacology. 50(1-2). 133–137. 9 indexed citations
17.
Stenbäck, Frej, et al.. (1994). Modification of hepatic cytochrome P450 profile by cocaine-induced hepatotoxicity in DBA/2 mouse. European Journal of Pharmacology Environmental Toxicology and Pharmacology. 292(1). 57–65. 15 indexed citations
18.
İşcan, Mümtaz, et al.. (1992). Cerium-induced strain-dependent increase in Cyp2a-45 (cytochrome P4502a-45) expression in the liver and kidneys of inbred mice. Biochemical Pharmacology. 44(7). 1269–1274. 26 indexed citations
19.
Raunio, Hannu, Markku Pasanen, P. Arvela, et al.. (1991). Comparison between cobalt and pyrazole in the increased expression of coumarin 7-hydroxylase in mouse liver. Biochemical Pharmacology. 41(3). 462–465. 22 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jukka Hakkola Breakdown of academic impact, for papers by Petr Pávek Breakdown of academic impact, for papers by Lauren M. Aleksunes Breakdown of academic impact, for papers by Ronald N. Hines Breakdown of academic impact, for papers by Janne Hukkanen Breakdown of academic impact, for papers by James W. Paxton Breakdown of academic impact, for papers by Hannu Raunio Breakdown of academic impact, for papers by Michael W.H. Coughtrie Breakdown of academic impact, for papers by Bhagwat Prasad Breakdown of academic impact, for papers by Angela L. Slitt
Rankless by CCL
2026